• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Pathfinder Cell Therapy

edit

athfinder Cell Therapy is developing a novel cell-based therapy for the treatment of diabetes, renal disease, myocardial infarction, and other diseases characterized by organ-specific cell damage. Pathfinder has discovered a new mammalian cell type, which is able to stimulate damaged tissues to regenerate without the Pathfinder Cells (“PCs”) themselves being incorporated into the new tissue.

Milestones

edit

• 
  Pathfinder Cell Therapy added Richard Franklin as Founder, CEO, and President.
  Posted 12/29/10 at 7:07pm
• 
  Pathfinder Cell Therapy — Pathfinder, SyntheMed merge (12/23/10)
  Posted 12/29/10 at 7:08pm via masshightech.com

Videos

Screenshots

edit

Sources

Pathfinder, SyntheMed merge (masshightech.com) [edit]